- My News
- All News
- Most Popular
Danaher's sales in the fourth quarter climbed 6 percent to $5.3 billion, topping analyst estimates of $5.2 billion, the company reported Tuesday. Meanwhile, profit for the three-month period reached $789.3 million, up 25 percent on the year-ago quarter.
In the quarter, sales from Danaher's Life Sciences & Diagnostics segment rose 5.5 percent year-over-year to $1.9 billion. Meanwhile, three-month sales from the company's dental segment increased 3.5 percent to $590 million.
CEO H. Lawrence Culp said "our strong finish in 2013 contributed to a solid year for Danaher overall," adding that the company is "well positioned for outperformance in 2014." Danaher reaffirmed its full-year guidance with earnings per share of between $3.60 and $3.75, on revenue growth of 2 percent to 4 percent. Analysts expect earnings per share of $3.77, on sales of $20.1 billion.
Did you like this article?